Loading...
Loading...
HUTCHMED (China) Ltd
HUTCHMED (China) Ltd. Spoken Alpha tracks HCM's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks HCM's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 80% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for HCM.
curl https://api.spokenalpha.com/v1/companies/HCM| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $0.61 | $0.51 | +18.8% | -0.5% | -3.3% |
| Q4 FY2026 | $0.79 | $0.61 | +29.3% | +2.5% | +5.0% |
| Q3 FY2026 | $0.65 | $0.54 | +20.6% | -0.5% | -1.7% |
| Q2 FY2026 | $0.68 | $0.52 | +30.1% | -4.4% | -3.2% |
| Q1 FY2025 | $0.72 | $0.58 | +23.4% | -5.8% | -8.2% |
| Q4 FY2025 | $0.58 | $0.45 | +28.4% | +0.9% | +1.2% |
| Q3 FY2025 | $0.87 | $0.67 | +30.3% | -7.5% | -7.7% |
| Q2 FY2025 | $0.78 | $0.62 | +26.5% | -5.4% | -5.2% |
| Q1 FY2024 | $0.70 | $0.58 | +20.5% | -6.4% | -3.6% |
| Q4 FY2024 | $0.90 | $0.68 | +32.1% | -6.7% | -6.2% |